These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 351717

  • 21. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
    Hauksson A, Akerlund M, Forsling ML, Kindahl H.
    J Endocrinol; 1987 Nov; 115(2):355-61. PubMed ID: 3125302
    [Abstract] [Full Text] [Related]

  • 22. The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.
    Lundström V.
    Acta Obstet Gynecol Scand; 1977 Nov; 56(3):167-72. PubMed ID: 878858
    [Abstract] [Full Text] [Related]

  • 23. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative.
    Lundström V.
    Acta Obstet Gynecol Scand; 1978 Nov; 57(5):421-8. PubMed ID: 103358
    [Abstract] [Full Text] [Related]

  • 24. [Can naproxen impair menstruation?].
    Meyboom RH, Bonsema K, Huisman-Klein Haneveld PM.
    Ned Tijdschr Geneeskd; 1989 Jul 01; 133(26):1326-7. PubMed ID: 2779679
    [Abstract] [Full Text] [Related]

  • 25. Severe, primary dysmenorrhea treated with naproxen. A prospective, double-blind, crossover investigation.
    Hamann GO.
    Prostaglandins; 1980 May 01; 19(5):651-7. PubMed ID: 6448429
    [Abstract] [Full Text] [Related]

  • 26. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea.
    Strömberg P, Forsling ML, Akerlund M.
    Obstet Gynecol; 1981 Aug 01; 58(2):206-8. PubMed ID: 7254732
    [Abstract] [Full Text] [Related]

  • 27. Plasma prostaglandin F 2-alpha levels in dysmenorrehic women.
    Shangold MM, Aksel S, Schomberg DW, Hammond CB.
    Fertil Steril; 1976 Oct 01; 27(10):1171-5. PubMed ID: 971774
    [Abstract] [Full Text] [Related]

  • 28. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
    Henzl MR, Ortega-Herrera E, Rodriguez C, Izu A.
    Am J Obstet Gynecol; 1979 Oct 15; 135(4):455-60. PubMed ID: 484644
    [Abstract] [Full Text] [Related]

  • 29. Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide.
    Pulkkinen MO.
    J Clin Pharmacol; 1987 Jan 15; 27(1):65-9. PubMed ID: 3680556
    [Abstract] [Full Text] [Related]

  • 30. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea.
    Rees MC, Anderson AB, Demers LM, Turnbull AC.
    Br J Obstet Gynaecol; 1984 Jul 15; 91(7):673-80. PubMed ID: 6589016
    [Abstract] [Full Text] [Related]

  • 31. The effect of exogenous intrauterine progesterone on the amount and prostaglandin F2alpha content of menstrual blood in dysmenorrheic women.
    Trobough G, Guderian AM, Erickson RR, Tillson SA, Leong P, Swisher DA, Pharriss BB.
    J Reprod Med; 1978 Sep 15; 21(3):153-8. PubMed ID: 722696
    [Abstract] [Full Text] [Related]

  • 32. Prostaglandins, indomethacin and dysmenorrhea.
    Lundström V, Gréen K, Wiqvist N.
    Prostaglandins; 1976 May 15; 11(5):893-907. PubMed ID: 935518
    [Abstract] [Full Text] [Related]

  • 33. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O, Joelsson I.
    Acta Obstet Gynecol Scand; 1981 May 15; 60(3):229-32. PubMed ID: 7270089
    [Abstract] [Full Text] [Related]

  • 34. The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I, Andersch B, Sundell G.
    Acta Obstet Gynecol Scand; 1988 May 15; 67(8):711-6. PubMed ID: 3074603
    [Abstract] [Full Text] [Related]

  • 35. Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.
    Hanson FW, Izu A, Henzl MR.
    Obstet Gynecol; 1978 Nov 15; 52(5):583-7. PubMed ID: 364357
    [Abstract] [Full Text] [Related]

  • 36. Central venous concentrations of immunoreactive prostaglandins E, F, and 6-keto-prostaglandin F1 in eclampsia.
    Moodley J, Norman RJ, Reddi K.
    Br Med J (Clin Res Ed); 1984 May 19; 288(6429):1487-9. PubMed ID: 6426613
    [Abstract] [Full Text] [Related]

  • 37. Diflunisal compared with naproxen in the treatment of dysmenorrhea.
    Kajanoja P, Kauste K.
    Prostaglandins Leukot Med; 1984 Aug 19; 15(2):153-8. PubMed ID: 6387717
    [Abstract] [Full Text] [Related]

  • 38. Naproxen sodium in dysmenorrhea secondary to endometriosis.
    Kauppila A, Rönnberg L.
    Obstet Gynecol; 1985 Mar 19; 65(3):379-83. PubMed ID: 3883265
    [Abstract] [Full Text] [Related]

  • 39. Clinical experience of naproxen in the treatment of primary dysmenorrhea.
    Dandenell LO, Lalos O, Lisciak J, Sandström B, Barany S, Nilsson B.
    Acta Obstet Gynecol Scand Suppl; 1979 Mar 19; 87():95-100. PubMed ID: 380256
    [Abstract] [Full Text] [Related]

  • 40. A rationale for the treatment of dysmenorrhea.
    Csapo AI.
    J Reprod Med; 1980 Oct 19; 25(4 Suppl):213-21. PubMed ID: 7001020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.